Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 1
Submit an article Journal homepage
3,139
Views
23
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

Nasamon Wanlapakorna Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Nungruthai Suntronwonga Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Harit Phowatthanasathiana Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Ritthideach Yorsaenga Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Preeyaporn Vichaiwattanaa Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Thanunrat Thongmeea Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Chompoonut Auphimaia Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Donchida Srimuana Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Thaksaporn Thatsanatorna Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Suvichada Assawakosria Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Sitthichai Kanokudoma Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
&
Yong Poovorawana Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;b FRS(T), The Royal Society of Thailand, Sanam Sueapa, Dusit, Bangkok, ThailandCorrespondence[email protected]
View further author information
 show all
Article: 2029111 | Received 04 Nov 2021, Accepted 11 Jan 2022, Published online: 24 Feb 2022

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Francesca Fortunato, Rosa Prato, Giuseppina Iannelli, Leonardo Ascatigno, Daniela Loconsole, Pier Luigi Lopalco & Domenico Martinelli. (2023) Safety of heterologous ChAdOx1-S/BNT162b2 primary schedule versus homologous BNT162b2 vaccination: Insights from an Italian post-marketing study, 2021. Human Vaccines & Immunotherapeutics 19:1.
Read now
Kriangkrai Tawinprai, Pawornrath Jungsomsri, Onnicha Pinijnai, Fahsiri Tavonvunchai, Anchisa Lievjaroen, Paphada Suwannaroj, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Gaidganok Sornsamdang & Teerapat Ungtrakul. (2023) Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study. Human Vaccines & Immunotherapeutics 19:1.
Read now
Saipin Pongsatha, Theera Tongsong, Jiraprapa Wipasa, Supachai Sakkhachornphop, Sayamon Hongjaisee & Kriangkrai Chawansuntati. (2023) A preliminary study on the effectiveness of maternal to neonatal transfer of antibodies against SARS-CoV-2 in the women vaccinated with heterologous CoronaVac–ChAdOx1. Human Vaccines & Immunotherapeutics 19:1.
Read now
Nussara Pakvisal, Panot Sainamthip, Nattaya Teeyapun, Sutima Luangdilok, Nassamon Wanlapakorn, Ritthideach Yorsaeng, Yong Poovorawan, Piyapoom Pakvisal, Thiti Susiriwatananont, Nicha Zungsontiporn, Virote Sriuranpong, Suebpong Tanasanvimon & Passakorn Wanchaijiraboon. (2022) Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls. Human Vaccines & Immunotherapeutics 18:6.
Read now

Articles from other publishers (19)

Catharina Gerhards, Margot Thiaucourt, Michael Hetjens, Verena Haselmann, Michael Neumaier & Maximilian Kittel. (2023) Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines. Vaccines 11:3, pages 701.
Crossref
Kun Xu, Zihan Wang, Maorong Qin, Yangyu Gao, Na Luo, Wanting Xie, Yihan Zou, Jie Wang & Xingming Ma. (2023) A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults. Frontiers in Immunology 14.
Crossref
Tavitiya Sudjaritruk, Oramai Mueangmo, Jutamad Saheng, Poramed Winichakoon, Parichat Salee, Worawan Wongjak, Tanachot Chaito, Jutarat Praparattanapan, Khanuengnit Nuket, Nuttarika Solai, Jiraprapa Wipasa, Kriangkrai Chawansuntati & Romanee Chaiwarith. (2023) Comparison of Immunogenicity and Reactogenicity of Five Primary Series of COVID-19 Vaccine Regimens against Circulating SARS-CoV-2 Variants of Concern among Healthy Thai Populations. Vaccines 11:3, pages 564.
Crossref
Tesfaye Gelanew, Liya Wassie, Andargachew Mulu, Liya Wondwossen, Markos Abebe, Adane Mihret & Alemseged Abdissa. (2023) Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?. Frontiers in Public Health 10.
Crossref
Saipin Pongsatha, Kriangkrai Chawansuntati, Supachai Sakkhachornphop & Theera Tongsong. (2023) Placental Transfer Immunity to the Newborns in a Twin Pregnant Women Vaccinated with Heterologous CoronaVac-ChAdOx1. Vaccines 11:1, pages 116.
Crossref
Mingkwan Wichaidit, Tanawin Nopsopon, Krittiyaporn Sunan, Phanupong Phutrakool, Puripant Ruchikachorn, Dittaya Wanvarie, Ploy Naruemon Pratanwanich, Nontawit Cheewaruangroj, Proadpran Punyabukkana & Krit Pongpirul. (2023) Breakthrough infections, hospital admissions, and mortality after major COVID-19 vaccination profiles: a prospective cohort study. The Lancet Regional Health - Southeast Asia 8, pages 100106.
Crossref
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, Ingo Fricke, Chinua Imarogbe & Karem H. Alzoubi. (2022) An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines. Vaccines 11:1, pages 51.
Crossref
Supachaya Sriphoosanaphan, Sirinporn Suksawatamnuay, Nunthiya Srisoonthorn, Nipaporn Siripon, Panarat Thaimai, Prooksa Ananchuensook, Kessarin Thanapirom, Bunthoon Nonthasoot, Pokrath Hansasuta & Piyawat Komolmit. (2022) Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study. Vaccines 10:12, pages 2126.
Crossref
Nungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, Suvichada Assawakosri, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Jira Chansaenroj, Jiratchaya Puenpa, Pornjarim Nilyanimit, Donchida Srimuan, Thaksaporn Thatsanatorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Juthathip Mongkolsapaya & Yong Poovorawan. (2022) Effects of boosted mRNA and adenoviral‐vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination. Journal of Medical Virology 94:12, pages 5713-5722.
Crossref
Natalia Vargas-Herrera, Manuel Fernández-Navarro, Nestor E. Cabezudo, Percy Soto-Becerra, Gilmer Solís-Sánchez, Stefan Escobar-Agreda, Javier Silva-Valencia, Luis Pampa-Espinoza, Ricardo Bado-Pérez, Lely Solari & Roger V. Araujo-Castillo. (2022) Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru. PLOS ONE 17:10, pages e0268419.
Crossref
Passakorn Wanchaijiraboon, Nattaya Teeyapun, Nussara Pakvisal, Panot Sainamthip, Thiti Susiriwatananont, Nicha Zungsontiporn, Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Worata Klinsawat, Nasamon Wanlapakorn, Suebpong Tanasanvimon, Virote Sriuranpong, Yong Poovorawan & Sutima Luangdilok. (2022) Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment. Vaccines 10:10, pages 1662.
Crossref
Nattaya Teeyapun, Sutima Luangdilok, Nussara Pakvisal, Panot Sainamthip, Siyamol Mingmalairak, Nattaya Poovorawan, Piyada Sitthideatphaiboon, Napa Parinyanitikul, Virote Sriuranpong, Teerayuth Namkanisorn, Pratchaya Inthasuwan, Pattama Angspatt, Ploytuangporn Wongchanapat, Akradach Bamrungnam, Nutchanok Leeleakpai, Sutheera Uttha, Supaporn Jaichum, Peerawich Kongkaew, Chayanin Suksanong, Rattiya Veranitinun, Ampai Prasomphol, Chada Sartsuk, Cheeraporn Patcharajutanon, Supreeya Preaprang, Hathairat Choengsamor, Rungthong Phongwan, Charoenpit Preeyasaksa, Ekkamol Phaibulvatanapong, Nungruthai Suntronwong, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Stephen J. Kerr, Yong Poovorawan, Passakorn Wanchaijiraboon & Suebpong Tanasanvimon. (2022) Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study. eClinicalMedicine 52, pages 101608.
Crossref
Sutima Luangdilok, Passakorn Wanchaijiraboon, Nussara Pakvisal, Thiti Susiriwatananont, Nicha Zungsontiporn, Virote Sriuranpong, Panot Sainamthip, Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Nattaya Teeyapun & Suebpong Tanasanvimon. (2022) Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine. Vaccines 10:10, pages 1613.
Crossref
Chih-Jung Chen, Lan-Yan Yang, Wei-Yang Chang, Yhu-Chering Huang, Cheng-Hsun Chiu, Shin-Ru Shih, Chung-Guei Huang & Kuan-Ying A. Huang. (2022) A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19. Nature Communications 13:1.
Crossref
Masoud Etemadifar, Hosein Nouri, Maristella Pitzalis, Maria Laura Idda, Mehri Salari, Mahshid Baratian, Sepide Mahdavi, Amir Parsa Abhari & Nahad Sedaghat. (2022) Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry 93:9, pages 986-994.
Crossref
Rapeepong Suphanchaimat, Natthaprang Nittayasoot, Chuleeporn Jiraphongsa, Panithee Thammawijaya, Punsapach Bumrungwong, Atthavit Tulyathan, Nontawit Cheewaruangroj, Chakkarat Pittayawonganon & Piyanit Tharmaphornpilas. (2022) Real-World Effectiveness of Mix-and-Match Vaccine Regimens against SARS-CoV-2 Delta Variant in Thailand: A Nationwide Test-Negative Matched Case-Control Study. Vaccines 10:7, pages 1080.
Crossref
Theerada Assawasaksakul, Tanat Lertussavavivat, Seelwan Sathitratanacheewin, Nont Oudomying, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Yingyos Avihingsanon, Nawaporn Assawasaksakul, Supranee Buranapraditkun & Wonngarm Kittanamongkolchai. (2022) Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study. Vaccines 10:6, pages 853.
Crossref
Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, Ritthideach Yorsaeng, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Chompoonut Auphimai, Lakkhana Wongsrisang, Sirapa Klinfueng, Natthinee Sudhinaraset & Yong Poovorawan. (2022) Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data. Vaccine 40:23, pages 3203-3209.
Crossref
Surakameth Mahasirimongkol, Athiwat Khunphon, Oraya Kwangsukstid, Sompong Sapsutthipas, Mingkwan Wichaidit, Archawin Rojanawiwat, Nuanjun Wichuckchinda, Wiroj Puangtubtim, Warangluk Pimpapai, Sakulrat Soonthorncharttrawat, Asawin Wanitchang, Anan Jongkaewwattana, Kanjana Srisutthisamphan, Daraka Phainupong, Naphatcha Thawong, Pundharika Piboonsiri, Waritta Sawaengdee, Thitiporn Somsaard, Kanokphon Ritthitham, Supaporn Chumpol, Nadthanan Pinyosukhee, Rattanawadee Wichajarn, Panadda Dhepakson, Sopon Iamsirithaworn & Supaporn Phumiamorn. (2022) The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine. Vaccines 10:4, pages 536.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.